PAVmed Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
839.10
767.30
585.70
1,535.00
8,222.10
Other Current Assets
3.00
8.80
155.50
88.50
238
Total Current Assets
842.10
776.00
741.20
1,623.50
8,460.20
Net Property, Plant & Equipment
-
-
18.00
16.20
36.30
Other Assets
-
438.10
111.30
-
-
Total Assets
842.10
1,214.10
870.40
1,639.70
8,496.40
Accounts Payable
-
-
-
864.40
Other Current Liabilities
47.20
580.20
1,189.50
1,679.40
Total Current Liabilities
47.20
580.20
1,189.50
2,543.80
Long-Term Debt
-
-
-
1,944.30
Total Liabilities
47.20
580.20
1,189.50
4,488.00
Common Equity (Total)
794.80
633.90
319.10
3,881.00
Total Shareholders' Equity
794.80
633.90
319.10
2,848.40
Total Equity
794.80
633.90
319.10
2,848.40
Liabilities & Shareholders' Equity
842.10
1,214.10
870.40
1,639.70
Preferred Stock (Carrying Value)
-
-
-
1,032.70

About PAVmed

View Profile
Address
One Grand Central Place
New York New York 10165
United States
Employees -
Website http://www.pavmed.com
Updated 07/08/2019
PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The company was founded on June 26, 2014 and is headquartered in New York, NY.